Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2019 | Precision medicine in gastrointestinal cancers: promise and pitfalls

Russell Petty • 5 Nov 2019
NCRI 2019
Esophageal Cancer Gastrointestinal Cancer

Russell Petty, BMSC, MB ChB, PhD, MRCP, University of Dundee, Dundee, UK, talks about the promise and pitfalls with precision medicine in gastrointestinal cancers. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.

More from Russell Petty

2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty • 5 Nov 2019

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals